EUVIMEDEUVIMED entdecken
Vergleichsstudie

Comparative Outcomes of Drug‐Eluting Balloons Versus Drug‐Eluting Stents in Patients With Diabetes Undergoing PPCI

Hassan Shabeer, Saba Sattar, F N U Arti, Haimath Kumar iD, Kashif Iltaf, Muhammad Zaryab Haider iD, Burhan Ul Haq Saqib, Muhammad Hassan Bari, Ali Karim iD, Sameet Kumar, F N U Shweta, F N U Payal und 3 weitere

Catheterization and Cardiovascular Interventions · 2025

DOI: 10.1002/ccd.70220 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Hassan Shabeer und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Ibn e Seena Hospital, Kabul, Afghanistan. Hauptthemen laut MEDLINE: Drug-Eluting Stents, Coronary Artery Disease, Angioplasty, Balloon, Coronary, Coated Materials, Biocompatible. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The comparative outcomes of DEB vs. DES in diabetic patients undergoing PPCI are of significant clinical interest, as these patients often experience higher rates of restenosis and adverse outcomes.

Aims

This study aimed to compare the outcomes of drug‐eluting balloons (DEB) versus drug‐eluting stents (DES) in diabetic patients undergoing primary percutaneous coronary intervention (PPCI).

Methods

We conducted a retrospective analysis of 5668 diabetic patients who underwent PPCI, with 1734 patients in the DEB group and 3934 patients in the DES group. Baseline characteristics, angiographic features, and clinical outcomes, including procedural success, major adverse cardiovascular events (MACE), target lesion revascularization (TLR), restenosis, and bleeding complications, were compared between the two groups.

Results

Both DEB and DES groups demonstrated high procedural success rates (97.6% and 98.4%, respectively), with no significant differences in MACE, death, myocardial infarction, or target vessel revascularization. Restenosis at 6 months occurred in 3.9% of the DEB group and 3.4% of the DES group ( p = 0.21). Lesion length, diabetes duration, hypertension, and prior myocardial infarction were identified as significant predictors of adverse outcomes. Use of DES was associated with a higher risk of MACE, but this did not translate into significant differences in clinical outcomes.

Conclusion

Both DEB and DES are effective and safe treatment options for diabetic patients undergoing PPCI, with comparable outcomes in terms of procedural success, MACE, and restenosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug-Eluting StentsCoronary Artery DiseaseAngioplasty, Balloon, CoronaryCoated Materials, BiocompatibleCardiac CathetersPercutaneous Coronary InterventionDiabetes MellitusHumansRetrospective StudiesMaleFemaleTreatment OutcomeMiddle AgedAgedTime FactorsRisk FactorsProsthesis DesignCoronary AngiographyCoronary Restenosis

Stichwörter der Autor:innen

diabetesdrug‐eluting balloonsdrug‐eluting stentsmajor adverse cardiovascular eventsprimary percutaneous coronary intervention

Substanzen

Coated Materials, Biocompatible

Autor:innen und Institutionen

  • Department of Medicine, Ibn e Seena Hospital, Kabul, Afghanistan.
  • Rawalpindi Institute of Cardiology, Rawalpindi, Pakistan.

ORCID-Profile: Haimath Kumar, Muhammad Zaryab Haider, Ali Karim, Abida Parveen

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Shabeer, H., Sattar, S., Arti, F. N. U., Kumar, H., Iltaf, K., Zaryab Haider, M., Haq Saqib, B. U., Hassan Bari, M., Karim, A., Kumar, S., Shweta, F. N. U., Payal, F. N. U., Rumela, F. N. U., Mastoi, M. G., & Parveen, A. (2025). Comparative Outcomes of Drug‐Eluting Balloons Versus Drug‐Eluting Stents in Patients With Diabetes Undergoing PPCI. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70220

Vancouver

Shabeer H, Sattar S, Arti FNU, Kumar H, Iltaf K, Zaryab Haider M, et al. Comparative Outcomes of Drug‐Eluting Balloons Versus Drug‐Eluting Stents in Patients With Diabetes Undergoing PPCI. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70220

BibTeX
@article{Shabeer2025,
  author = {Shabeer, Hassan and Sattar, Saba and Arti, F N U and Kumar, Haimath and Iltaf, Kashif and Zaryab Haider, Muhammad and Haq Saqib, Burhan Ul and Hassan Bari, Muhammad and Karim, Ali and Kumar, Sameet and Shweta, F N U and Payal, F N U and Rumela, F N U and Mastoi, Mehak Gul and Parveen, Abida},
  title = {Comparative Outcomes of Drug‐Eluting Balloons Versus Drug‐Eluting Stents in Patients With Diabetes Undergoing PPCI},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2025},
  doi = {10.1002/ccd.70220}
}
Kostenlos starten →